The trading window shall remain closed for trading in share of the company from 1st October 2026 till completion of the 48 hours of declaration of unaudited standalone and consolidated financial results for the quarter and half year ended 30.09.2026.

MEDI-CAPS LIMITED CIN: L70100MP1983PLC002231 MCL/SE/BSE/2026-27 Date: 25.09.2026 Online Filing at: www.listing.bseindia.com The General Manager, DCS-CRD BSE Limited Phiroze Jeejeebhoy Towers Dalal Street Mumbai -400001 (M.H.) SUBJECT: INTIMATION FOR CLOSURE OF TRADING WINDOW REFERENCE: MEDI-CAPS LIMITED (BSE SCRIP CODE: 523144, ISIN: INE442D01010) Dear Sir/Madam, This is with reference to the BSE Circular Ref. No. LIST/COMP/01/2019-20 dated 02nd April, 2019, we wish to inform you that in terms of the Company’s Code of Conduct to regulate, monitor and report trading in Company’s Securities by Insiders Framed under SEBI (Prohibition of Insider Trading) Regulations 2015, the Trading Window for dealing in the securities of the Company will remain closed for all Designated Persons, their immediate relatives and all connected persons (as defined in the Code) w.e.f. 01st October, 2026 for the purpose of consideration of Unaudited Standalone and consolidated Financial Results for quarter and half year ended on 30th September, 2026. This is further informed that the Company has also complied with the requirements of Securities and Exchange Board of India (SEBI) Circular No. SEBI/HO/ISD/ISD-SEC-4/P/CIR/2022/107 dated August 5, 2022 , SEBI/HO/ISD/ISD- PoD-2/P/CIR/2023/124 dated July 19, 2023 and SEBI/HO/ISD/ISD-PoD-2/P/CIR/2025/55 dated April 21, 2025 regarding Trading Window Closure period under Clause 4 of Schedule B read with Regulation 9 of SEBI (Prohibition of Insider Trading) Regulations, 2015 (“PIT Regulations”) framework for restricting trading by Designated Persons (“DPs”) by freezing PAN at security level. The Trading Window shall open 48 hours after the Unaudited Standalone and consolidated Financial Results for the quarter and half year ended on 30th September, 2026, become generally available i.e. declaration of these Results to the Stock Exchange. All the Directors, KMP’s, Designated Employees, Connected Persons, Fiduciaries and their immediate relatives are advised not to deal in the securities of the Company either directly or indirectly during the aforesaid period. Further, we are submitting the above said information in XBRL mode (excel template provided by Exchange) along with the submission in PDF mode within prescribed time limit. The date of meeting of the Board of Directors to approve the Un-Audited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended on 30th September, 2026 will be intimated in due course. You are requested to please take on record above said information for your reference. Thanking You. Yours Faithfully, For, MEDI-CAPS LIMITED ABHISHEK JAIN COMPANY SECRETARY & COMPLIANCE OFFICER M. NO.: A36699 Encl: Copy of Circular REGISTERED OFFICE 201, PUSHPRATNA PARADISE, 9/5 NEW PALASIYA INDORE – 452001 PH:- 0731-4028148, FAX:- 0731-4041435 E mail:- investors@medicaps.com, Web site:- www.medicaps.com MEDI-CAPS LIMITED CIN: L70100MP1983PLC002231 CIRCULAR Dated: 25.09.2026 All the Designated persons, Directors, KMP’s, Designated Employees, connected persons, Fiduciaries and their immediate relatives of Medi-Caps Limited SUBJECT: NOTICE FOR CLOSURE OF TRADING WINDOW Pursuant to SEBI (Prohibition of Insider Trading) Regulation, 2015 read with BSE Circular No. LIST/COMP/01/2019-20 dated 2nd April, 2019 and Company’s Internal Code of procedure and Conduct; All the Designated persons, Directors, KMP’s, Designated Employees, connected persons, Fiduciaries and their immediate relatives may deal in the shares of the company on any working day during the trading hours as prescribed by the stock exchange (this shall be called “Trading window”) except during the closure of Trading Window. The window for trading in the shares of the Company shall remain close from 1st October, 2026 till completion of 48 hours after the declaration of the Un-audited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended on 30th September, 2026 to the Stock Exchange. All the Directors, KMP’s, Designated Persons/Employees, connected persons, Fiduciaries and their immediate relatives are advised not to deal in the shares of the Company either directly or indirectly during this Closure of Trading Window. The date of meeting of the Board of Directors to consider and approve the unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended on 30th September, 2026, will be informed in due course. For, MEDI-CAPS LIMITED ABHISHEK JAIN COMPANY SECRETARY & COMPLIANCE OFFICER M. NO.: A36699 Note: 1. Designated Persons/Employees includes Board of the Directors and the Employees holding designations in the Company e.g Directors, KMP’s and all employees of Accounts/Finance Department, Secretarial Department and their immediate relatives. 2. All the connected persons, including the Statutory, Internal and Secretarial Auditors, designated employees of the Banks, and Share Transfer Agent, etc. and their immediate relatives. 3. Dealing in the equity shares, means an act of buying, selling or agreeing to buy, sell, or deal in any shares of the Company by any Designated Employees either as principal or agent. REGISTERED OFFICE 201, PUSHPRATNA PARADISE, 9/5 NEW PALASIYA INDORE – 452001 PH:- 0731-4028148, FAX:- 0731-4041435 E mail:- investors@medicaps.com, Web site:- www.medicaps.com